Presentation is loading. Please wait.

Presentation is loading. Please wait.

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial  Kaarina.

Published byMaija-Liisa Nurmi Modified over 6 years ago

Similar presentations

Presentation on theme: "Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial  Kaarina."— Presentation transcript:

1 Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial  Kaarina Kukkonen, MD, Erkki Savilahti, MD, PhD, Tari Haahtela, MD, PhD, Kaisu Juntunen-Backman, MD, PhD, Riitta Korpela, PhD, Tuija Poussa, MSc, Tuula Tuure, PhD, Mikael Kuitunen, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 119, Issue 1, Pages (January 2007) DOI: /j.jaci Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Diagram showing the flow of participants in the probiotic and placebo groups. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial  Kaarina."

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort  Mikael Kuitunen, MD, PhD, Kaarina.

Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort  Mikael Kuitunen, MD, PhD, Kaarina.
Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema– dermatitis syndrome  Mirva Viljanen, MD, Emma Pohjavuori, MD, Tari.

Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema– dermatitis syndrome  Mirva Viljanen, MD, Emma Pohjavuori, MD, Tari.
Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,

Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria  Matt Morgan, MD, Andrew Cooke, MD, Laura Rogers,
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial  Kristin Wickens, PhD,

A differential effect of 2 probiotics in the prevention of eczema and atopy: A double- blind, randomized, placebo-controlled trial  Kristin Wickens, PhD,
Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo- controlled clinical trial  Peter Bager, PhD, John Arnved, MD, Steen.

Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo- controlled clinical trial  Peter Bager, PhD, John Arnved, MD, Steen.
Allergen immunotherapy: A practice parameter third update

Allergen immunotherapy: A practice parameter third update
Pharmacologic rationale for treating allergic and nonallergic rhinitis

Pharmacologic rationale for treating allergic and nonallergic rhinitis
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials  Carlos A. Cuello-Garcia, MD, Jan L. Brożek,

Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials  Carlos A. Cuello-Garcia, MD, Jan L. Brożek,
Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.

Major rabbit allergen Ory c 3: What could be its possible role as a sensitizing agent in real life?  Gennaro Liccardi, MD, Antonello Salzillo, MD, Maria.
Ophthalmologic findings in children with asthma receiving inhaled budesonide  Anna Pelkonen, MD, PhD, Osmo Kari, MD, PhD, Olof Selroos, MD, PhD, Kurt Nikander,

Ophthalmologic findings in children with asthma receiving inhaled budesonide  Anna Pelkonen, MD, PhD, Osmo Kari, MD, PhD, Olof Selroos, MD, PhD, Kurt Nikander,
Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial  Thomas R. Abrahamsson, MD, Ted Jakobsson, MD,

Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial  Thomas R. Abrahamsson, MD, Ted Jakobsson, MD,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,

Similar presentations

Ads by Google